1. Home
  2. PROK vs WEYS Comparison

PROK vs WEYS Comparison

Compare PROK & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProKidney Corp.

PROK

ProKidney Corp.

HOLD

Current Price

$1.41

Market Cap

316.0M

Sector

Health Care

ML Signal

HOLD

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

N/A

Current Price

$45.80

Market Cap

331.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
PROK
WEYS
Founded
2015
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Apparel
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
316.0M
331.9M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
PROK
WEYS
Price
$1.41
$45.80
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$7.40
N/A
AVG Volume (30 Days)
1.0M
18.9K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
3.24%
EPS Growth
N/A
N/A
EPS
N/A
2.04
Revenue
$893,000.00
$276,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$22.91
Revenue Growth
1075.00
N/A
52 Week Low
$1.41
$27.25
52 Week High
$3.48
$48.68

Technical Indicators

Market Signals
Indicator
PROK
WEYS
Relative Strength Index (RSI) 34.85 73.18
Support Level N/A $30.98
Resistance Level $2.59 N/A
Average True Range (ATR) 0.09 1.88
MACD -0.00 0.59
Stochastic Oscillator 0.03 72.62

Price Performance

Historical Comparison
PROK
WEYS

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.

Share on Social Networks: